BUSINESS WIRE)--Alector, Inc. (Nasdaq: ALEC), a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic ... read more
Alector Announces Pricing of Initial Public Offering
Alector Announces Pricing of Initial Public Offering